Janux Therapeutics
JANX
$64.78
Share price
3.76%
Change (1 day)
331.87%
Change (1 year)
Categories
Janux Therapeutics (JANX) - Cash on Hand
Cash on Hand as of December 2023 : $0.34 B
According to Janux Therapeutics's latest financial reports the company has $0.34 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Janux Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.34 B | 5.2% |
| 2022-12-31 | $0.32 B | -12.79% |
| 2021-12-31 | $0.37 B | 4699.24% |
| 2020-12-31 | $7.81 M | 1087.39% |
| 2019-12-31 | $0.65 M |